Foley Hoag LLP


U.S. law firm providing litigation, transactional, regulatory and advisory legal services across industries including technology, life sciences, healthcare, finance, international arbitration, and public international law. Practice strengths include appellate and trial advocacy, bankruptcy and restructuring, private equity and M&A, international trade and arbitration, product liability, intellectual property and licensing, healthcare regulatory and data privacy, tax controversy and tax-credits/project finance, and representation of sovereign and state clients. The firm operates a foundation funded from pro bono awards to support programs addressing inequity.

Industries

finance
intellectual-property
legal
venture-capital-b37d

Nr. of Employees

small (1-50)

Foley Hoag LLP


Products

Life Sciences Legal Practice

Legal services supporting development and commercialization of medical products and services.

Healthcare Law and Policy Advisory

Legal and policy advice on healthcare compliance, government investigations, litigation, and transactions.

International Litigation and Arbitration

Representation in complex international disputes, including state-to-state and investor-state arbitration.

Corporate and Transactional Legal Services

Legal support for mergers and acquisitions, capital markets, private equity, debt finance, and corporate governance.

Intellectual Property Legal Services

Legal counsel on intellectual property management, licensing, litigation, and patent proceedings.

Litigation and Investigations

Representation in commercial litigation, government investigations, class actions, and regulatory enforcement matters.


Services

State and federal appellate briefs and oral argument, amicus filings and appellate strategy.

Debtor, creditor, committee and purchaser representation in Chapter 11, restructuring negotiations, adversary proceedings and distressed asset transactions.

Deal structuring, due diligence, financing, recapitalizations and representation of sponsors, management and co-investors in private equity transactions.

Defense in complex product and mass‑tort litigation for pharmaceuticals, medical devices and consumer products, plus safety audits to assess design, manufacturing and labeling risk.

Structuring and negotiating royalty monetizations and related IP licensing, valuation and exclusivity counseling for universities, non-profits and life‑sciences companies.

Regulatory, compliance, policy development and litigation counseling addressing reproductive‑health legal issues and cross‑jurisdictional provider obligations.

View All Services

Expertise Areas

  • Appellate advocacy
  • Bankruptcy and restructuring
  • Distressed M&A and Section 363 transactions
  • Private equity and M&A transactions
  • Show More (18)

Key Technologies

  • Appellate and amicus-brief strategy
  • Chapter 11 reorganization and avoidance litigation
  • Section 363 asset sale procedures
  • Trade-remedy and WTO/FTA dispute procedures
  • Show More (12)

News & Updates

Rapid-response webinar and briefing addressing operational, disclosure and legal issues arising from the Silicon Valley Bank collapse.

Firm reception at the BIO industry event.

Alert on public-company disclosure and securities implications following the Silicon Valley Bank closure.

Practice alert on disclosure obligations and public-company considerations after the Silicon Valley Bank failure.

Alert summarizing FDIC actions and FAQs for affected depositors and borrowers.

Publication addressing implications of a bankruptcy decision for directors-and-officers insurance programs.

View All News

Similar organizations

Browse all ORGANIZATIONS

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.